Further well-designed multicentric studies with NAT2 genotyping among large and geographically and ethnically diverse TB and AT-DILI populations with a dynamic follow-up could overcome the limitations of our research and several other literatures on TB patients that were included in the current study of having smaller AT-DILI populations. The gene discussed is NAT2; the disease is tuberculosis.